Form 4: Astera Labs General Counsel Sells Shares for Tax Obligations
Insider Transaction Report
Astera Labs' General Counsel, Philip Mazzara, sold 4,620 shares of common stock on November 17, 2025, to cover tax withholding obligations related to restricted stock unit vesting.
Summary
- Philip Mazzara, General Counsel and Secretary of Astera Labs, Inc. (ALAB), reported transactions on a Form 4 filing.
- On November 17, 2025, Mr. Mazzara disposed of a total of 4,620 shares of Astera Labs Common Stock across four separate transactions.
- The sales were executed at weighted average prices ranging from $143.5145 to $146.4164 per share.
- These sales were non-discretionary, mandated to satisfy tax withholding obligations in connection with the vesting and settlement of previously granted restricted stock units (RSUs).
- Following these transactions, Mr. Mazzara beneficially owns 147,040 shares of Astera Labs Common Stock directly.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the reported transactions are non-discretionary sales for tax purposes, a routine event for executives, and do not reflect a change in investment sentiment by the insider.
Future Outlook
This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.
Management Comments
- The reported sales represent shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted.
- Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a 'sell to cover', and do not represent a discretionary trade by the Reporting Person.
Industry Context
The 'sell to cover' transaction reported by Astera Labs' General Counsel is a common and routine practice for executives receiving equity compensation. It is a standard mechanism to fund tax liabilities arising from the vesting of restricted stock units, rather than an indication of a discretionary investment decision.
Stakeholder Impact
- Shareholders: Minimal direct impact as the transaction is a routine, non-discretionary tax-related sale by an insider, not indicative of a change in company fundamentals or insider sentiment.
Key Dates
| Date | Description |
|---|---|
| 11/17/2025 | Date of earliest transaction for the sale of common stock. |
| 11/19/2025 | Date the Form 4 was signed by the reporting person. |
Recommendation
holdThe reported insider transaction is a non-discretionary 'sell to cover' to satisfy tax obligations from RSU vesting. This is a routine event and does not signal any change in the company's fundamentals or the insider's confidence in the company. Therefore, it does not warrant a change in investment recommendation based solely on this filing.
Keywords
Astera Labs, ALAB, Form 4, Insider Transaction, Stock Sale, Restricted Stock Units, Tax Withholding, Philip Mazzara, Corporate Officer
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.